The constitutively activated tyrosine kinases (TKs) are hallmark features of several types of cancer, such as chronic myeloid leukemia (CML) and Ph+ ALL. This evidence concerns the gene CDC42 and chronic myelogenous leukemia, BCR-ABL1 positive.